Why does GM1 induce a potent beneficial response to experimental Chagas disease?
- PMID: 19794814
- PMCID: PMC2707790
- DOI: 10.2976/1.3067922
Why does GM1 induce a potent beneficial response to experimental Chagas disease?
Abstract
Being one of the world's neglected diseases, Chagas has neither a vaccine nor a satisfactory therapy. Inoculation of murine models with the ganglioside GM1 has shown a strikingly nonlinear effect, leading to a strong decrease in parasite load at low doses but reverting to a load increase at high doses. Cardiocyte destruction concomitant with the disease is also significantly reduced by a moderate application of GM1. A mathematical model for the interaction between the parasite and the immune system is shown to explain these effects and is used to predict an optimal dosage that maximizes parasite removal with minimal cardiocyte destruction.
Figures
References
-
- Andrade, A LSS, et al. (1996). “Randomized trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.” Lancet 348, 1407–1413. - PubMed
-
- Brener, Z (1980). “Immunity to Trypanosoma cruzi.” Adv. Parasitol. 18, 247–292. - PubMed
-
- Bronia, D H, Aguerri, A M, and Bertetto, S T (1986). “Trypanosoma cruzi: changes in lipid composition during aging in culture.” Exp. Parasitol. 61, 151–159. - PubMed
LinkOut - more resources
Full Text Sources